Medpulser Electroporation with Bleomycin

COMBINATION_PRODUCT4 trials

Sponsors

Inovio Pharmaceuticals

Conditions

CancerHead Neck CancerHead and Neck Cancer

Phase 3

Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma

TerminatedNCT00198315

Inovio PharmaceuticalsHead and Neck Cancer

Start: 2004-06-30End: 2007-06-01Updated: 2022-03-04

Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

TerminatedNCT00198328

Inovio PharmaceuticalsHead Neck Cancer

Start: 2004-11-30End: 2007-06-30Updated: 2022-03-04

Phase 4

Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer

CompletedNCT00198276

Inovio PharmaceuticalsCancer

Start: 2004-02-29End: 2008-09-30Updated: 2017-10-03

Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer

CompletedNCT00198263

Inovio PharmaceuticalsHead and Neck Cancer

Start: 2004-01-31End: 2008-09-30Updated: 2017-10-03